Related Experiment Videos
Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats
D A Shear1, K L Haik, G L Dunbar
1Department of Psychology, Central Michigan University, Mt. Pleasant 48859, USA.
Neuroreport
|July 7, 2000
Summary
Creatine supplementation protected rats from 3-nitropropionic acid (3NP)-induced brain damage and behavioral issues similar to Huntington
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder.
- 3-nitropropionic acid (3NP) is used to model HD-like symptoms in rodents.
- Neuropathological and behavioral deficits are key features of 3NP-induced neurodegeneration.
Purpose of the Study:
- To investigate the neuroprotective effects of creatine against 3NP-induced abnormalities.
- To assess creatine's potential therapeutic role in Huntington's disease models.
Main Methods:
- Rats received either creatine or control diets for 2 weeks before and during 8 weeks of 3NP administration.
- 3NP was administered systemically with gradually increasing concentrations.
- Neuropathological changes (lesions, atrophy, ventricular enlargement) and behavioral deficits (cognitive, motor) were evaluated.
Main Results:
- Creatine attenuated 3NP-induced striatal lesions and atrophy.
- Creatine reduced ventricular enlargement in the brain.
- Creatine improved cognitive function and motor coordination in 3NP-treated rats.
Conclusions:
- Creatine demonstrates significant neuroprotective effects against 3NP-induced damage.
- Creatine supplementation may offer a therapeutic strategy for Huntington's disease.